Patients with a homozygous deletion of SMN1 and a high SMN2 copy number have a phenotype [8–10] due to the small fraction of normal transcripts, which indicates that infants with a homozygous mutation on c.840 of C > T will have symptoms of SMA. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.